Table 1 Relationship between miR-328-3p expression and tumour clinicopathologic features.
From: Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy
Clinical and pathological features | N | miRNA-328-3p expression | ||||
|---|---|---|---|---|---|---|
Low | % | High | % | P value | ||
All cases | 60 | 34 | 56.7 | 26 | 43.3 | |
Age | 0.205 | |||||
<60 | 29 | 14 | 41.2 | 15 | 57.7 | |
>=60 | 31 | 20 | 58.8 | 11 | 42.3 | |
Sex | 0.211 | |||||
Female | 42 | 26 | 76.5 | 16 | 61.5 | |
Male | 18 | 8 | 23.5 | 10 | 38.5 | |
Lymphatic metastasis | 0.030 | |||||
Positive | 22 | 18 | 52.9 | 4 | 15.4 | |
Negative | 38 | 16 | 47.1 | 22 | 84.6 | |
TNM stage | <0.001 | |||||
T1N0M0 | 21 | 7 | 20.6 | 14 | 53.8 | |
T2N0M0 | 24 | 13 | 38.2 | 11 | 42.4 | |
T3N0M0 | 15 | 14 | 41.2 | 1 | 3.8 | |
Tumour differentiation | 0.018 | |||||
Well | 31 | 9 | 26.5 | 22 | 84.6 | |
Moderate | 29 | 25 | 73.5 | 4 | 15.4 | |
